Correction for hidden confounders in the genetic analysis of gene expression

  1. David Heckermana,1
  1. aMicrosoft Research, 1100 Glendon Avenue, Suite PH1, Los Angeles, CA;
  2. bMicrosoft Research, 1 Microsoft Way, Redmond, WA; and
  3. cPacific Biosciences, 1505 Adams Drive, Menlo Park, CA
  1. Edited* by David Haussler, University of California, Santa Cruz, CA, and approved July 21, 2010 (received for review February 26, 2010)

Abstract

Understanding the genetic underpinnings of disease is important for screening, treatment, drug development, and basic biological insight. One way of getting at such an understanding is to find out which parts of our DNA, such as single-nucleotide polymorphisms, affect particular intermediary processes such as gene expression. Naively, such associations can be identified using a simple statistical test on all paired combinations of genetic variants and gene transcripts. However, a wide variety of confounders lie hidden in the data, leading to both spurious associations and missed associations if not properly addressed. We present a statistical model that jointly corrects for two particular kinds of hidden structure—population structure (e.g., race, family-relatedness), and microarray expression artifacts (e.g., batch effects), when these confounders are unknown. Applying our method to both real and synthetic, human and mouse data, we demonstrate the need for such a joint correction of confounders, and also the disadvantages of other possible approaches based on those in the current literature. In particular, we show that our class of models has maximum power to detect eQTL on synthetic data, and has the best performance on a bronze standard applied to real data. Lastly, our software and the associations we found with it are available at http://www.microsoft.com/science.

Footnotes

  • 1To whom correspondence may be addressed. E-mail: jennl{at}microsoft.com and heckerma@microsoft.com.
  • Author contributions: J.L., E.E.S., and D.H. designed research; J.L. performed research; J.L. and C.K. contributed new reagents/analytic tools; J.L. analyzed data; and J.L. and D.H. wrote the paper.

  • Conflict of interest statement: Eric E. Schadt is Chief Scientific Officer of Pacific Biosciences and owns stock in the company.

  • *This Direct Submission article had a prearranged editor.

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1002425107/-/DCSupplemental.

    Freely available online through the PNAS open access option.

    OPEN ACCESS ARTICLE